Daina Graybosch
Stock Analyst at Leerink Partners
(0)
# 4667
Out of 5,329 analysts
132
Total ratings
28.41%
Success rate
-19.98%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TSVT 2seventy bio | Downgrades: Market Perform | 9 5 | 5 | 0% | 6 | Mar 11, 2025 | |
MRK Merck & Co | Maintains: Outperform | 136 119 | 83.59 | 42.36% | 19 | Jan 13, 2025 | |
LVTX LAVA Therapeutics | Downgrades: Market Perform | 11 2 | 1.26 | 58.73% | 6 | Dec 12, 2024 | |
BOLT Bolt Biotherapeutics | Downgrades: Market Perform | 3 1 | 0.36 | 177.78% | 8 | May 15, 2024 | |
ACLX Arcellx | Maintains: Outperform | 35 39 | 66.03 | -40.94% | 5 | Mar 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 3 | 0.76 | 294.74% | 10 | Feb 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 14 | 0.55 | 2445.45% | 4 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 62 10 | 1.29 | 675.19% | 7 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 60 | 0.97 | 6085.57% | 7 | Dec 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 10 9 | 2.27 | 296.48% | 10 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 38 | 8.96 | 324.11% | 2 | Nov 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 8 | 3.75 | 113.33% | 4 | Aug 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 223 224 | 105.4 | 112.52% | 16 | Jul 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | 2.06 | 1356.31% | 1 | Jul 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 21 7 | n/a | n/a | 4 | Jun 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 59 | 7.65 | 671.24% | 7 | May 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 17 | 0.9 | 1788.89% | 3 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 25 2 | n/a | n/a | 6 | Apr 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 9 | 1.53 | 488.24% | 4 | Feb 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | n/a | n/a | 2 | Apr 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 68 | n/a | n/a | 1 | Dec 11, 2019 |